Following the mention in certain media outlets regarding the unavailability of the Naloxone antidote against opioid overdoses, we wish to inform of that Sandoz Canada has the necessary supply to ensure access to S.O.S. Naloxone™ Hydrochloride Injection and it is available to all Canadian pharmacies that wish to obtain it.
Erelzi™ has been approved for use in Canada in a manner similar to Enbrel®, for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis1.
Where people lack access to basic medicines, common illnesses can be deadly. Sandoz has recently deepened its ongoing support of Americares, a global health nonprofit that provides donated medication and health programs for people in need.
This site is intended for an audience in Canada